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98Objective: Patients with Stanford type B acute aortic dissection usually receive medical treatment during the
acute phase. The present study aimed to elucidate the factors predicting late aortic events in patients treated
conservatively for acute type B dissections.
Methods: From March 1991 to March 2011, 117 patients were enrolled in the present study, with a mean
follow-up period of 5.1 4.1 years. The patients were divided into 4 groups according to their false lumen status
at onset: group F, fully open (n ¼ 26, 22.2%); group P, partially thrombosed (n ¼ 23, 19.6%); group U,
ulcer-like projections (n ¼ 22, 18.9%); and group T, completely thrombosed (n ¼ 46, 39.3%).
Results: Long-term survival did not significantly differ among the groups. The Kaplan-Meier event-free rate
curve showed that aortic events occurred less frequently in group T than in the other 3 groups; the 5-year
event-free rate was 65.4%, 58.8%, 36.1%, and 95.7% for groups F, P, U, and T, respectively. Cox regression
analysis showed that the presence of ulcer-like projections (P ¼ .016) and a maximum aortic diameter
of  40 mm (P ¼ .003) were predictors of late aortic events.
Conclusions: When patients have a maximum aortic diameter of 40 mm or ulcer-like projections at
onset, early surgical intervention should be considered to prevent positive remodeling of the aorta. (J Thorac
Cardiovasc Surg 2014;148:98-104)Patients with Stanford type B acute aortic dissections
(AADs), without complications such as rupture or organ
ischemia, are usually treated medically during the acute
phase. The in-hospital outcomes have generally been
acceptable for patients with uncomplicated acute type B
dissections, with 90% surviving to hospital discharge after
receiving effective antihypertensive therapy.1 The short-
and long-term prognoses, after discharge from the hospital,
remain unclear, with some dissected aortas remaining
unchanged and some requiring intervention for enlargement
or rupture. The findings from previous studies have been
inconsistent, with 1-year survival rates of 56% to 92%
and 5-year rates of 48% to 82%.2-6
At onset, the determination of which patients are likely to
experience aortic events during the chronic phase is
difficult. However, in terms of late events, patients with
patent false lumens have been observed to have poorer
outcomes than those with completely thrombosed false
lumens. In the present study, we compared the clinicale Division of Cardiac Surgery, Department of Surgery and Clinical Science,
guchi University Graduate School of Medicine, Yamaguchi, Japan.
res: Authors have nothing to disclose with regard to commercial support.
d for publication April 16, 2013; revisions received June 25, 2013; accepted
blication July 12, 2013; available ahead of print Sept 11, 2013.
for reprints: Kimikazu Hamano, MD, PhD, Division of Cardiac Surgery,
rtment of Surgery and Clinical Science, Yamaguchi University Graduate
l of Medicine, 1-1-1, Minamikogushi, Ube, Yamaguchi 755-8505, Japan
il: kimikazu@yamaguchi-u.ac.jp).
23/$36.00
ht  2014 by The American Association for Thoracic Surgery
.doi.org/10.1016/j.jtcvs.2013.07.047
The Journal of Thoracic and Cardiovascular Surgefeatures and prognoses of patients with type B AAD, who
were categorized into 4 groups according to the false lumen
status: completely open (group F), partially thrombosed
(group P), ulcer-like projections (ULPs; group U), and
completely thrombosed (group T). The patients were
followed up for a protracted period to identify the potential
predictors of late aortic events using the patient parameters
at onset. We hypothesized that predicting the risk factors on
the basis of morphologic features, ensuring close follow-up,
and performing the required surgical intervention might
improve the long-term outcomes of patients with uncomp-
licated type B AAD.METHODS
Study Population
From March 1991 to March 2012, 168 patients received conservative
treatment of type B AAD. Among these patients, follow-up imaging was
performed for 117 patients, who were included in the present study. The
mean follow-up period was 5.1  4.1 years (range, 0.1-20.1), with a
follow-up rate of 70.9%. The mean patient age, at onset, was 68.9 
11.3 years (range, 38-95), and 36 patients (30.7%) were women (Table 1).
Diagnosis and Predictive Variables
The diagnosis of type B AAD was confirmed using contrast-enhanced
computed tomography (CT) immediately after emergency admission.
The data were reviewed by an experienced radiologist in a blinded manner.
The results of these radiologic examinations provided data regarding the
false lumen status (fully open, partially thrombosed, ULPs, or completely
thrombosed) and the maximum diameter of the dissected aorta (Figure 1).
The maximum aortic diameter (AD) was defined as the largest short-axis
diameter of the outer contour of the aorta in the axial direction. This was
measured, at least twice, on the initial CT images and on the most recentry c July 2014
Abbreviations and Acronyms
AAD ¼ acute aortic dissection
AD ¼ aortic diameter
CT ¼ computed tomography
TEVAR ¼ thoracic endovascular aortic repair
ULPs ¼ ulcer-like projections
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chronic phase, the AD was measured on the CT images obtained
immediately before surgery. The mean aortic enlargement rate was
obtained by dividing the difference in the maximumAD between the initial
and the most recent CT images by the interval between imaging
examinations. These data and the basic patient characteristics (eg, age,
gender, hypertension, and smoking status) are listed in Table 1.
The 117 patients were categorized into 4 groups, according to the
clinical features associated with the false lumen status. We defined a
thrombosed false lumen as a false lumen that was not enhanced in the early
or delayed phase. Of the 117 patients, 46 (39.3%) had a completely
thrombosed false lumen (group T). ULPs were defined as any focal
blood-filled pouch projecting into the thrombosed false lumen; 22 patients
(18.9%) fulfilled this definition (group U). A patent false lumen was
defined as a false lumen that was enhanced completely at an early or
delayed phase, and 26 patients (22%, group F) had a patent false lumen.
Finally, 23 patients (19.6%) had partial thrombosis of the false lumen in
which both flow and a thrombus were present (group P; partially
thrombosed false lumen). We investigated the predictors of late aortic
events that required open surgery or thoracic endovascular aortic repair
(TEVAR). The late aortic events were defined as malperfusion or progres-
sive aortic pathologic features, including rupture and expansion.
Treatment and Follow-up
Most patients with type B AAD received calcium channel blockers by
continuous intravenous infusion to control their blood pressure, immedi-
ately after admission. If oral administration was possible, oral formulations
of these agents were administered. The patients received b-blockers
(58.1%) concurrently with additional calcium channel blockers (87.2%),
angiotensin II receptor blockers (49.6%), angiotensin-converting enzymes
(16.7%), and diuretics (11.1%), as appropriate. While maintaining
adequate urine production, the blood pressure was controlled with a target
systolic level of 100 to 120 mmHg. After discharge, the patients continued
to receive oral medications, and the blood pressure was controlled to
<120 mm Hg.
Surgery was performed on patients with complications, such as rupture
or an increased AD. The indications for surgical intervention were
expansion of the AD by 5 mm/y or a maximum AD of>60 mm.TABLE 1. Basic characteristics of all groups
Characteristic
Group F
(n ¼ 26; 22.2%)
Grou
(n ¼ 23;
Age (y) 62.6  10.8 68.3 
Female gender (%) 19.2 34
Hypertension (%) 88.5 78
Smoking (%) 73.1 60
Dissection extent, DeBakey type IIIb 25 (96.2) 19 (8
Maximum AD at onset (mm) 40.5  6.9 40.7 
Data presented as mean  standard deviation, %, or n (%). Group F, Fully open false l
Group T, completely thrombosed false lumen; NS, not significant; AD, aortic diameter. *P<
zP<.05, group F versus group T and group U versus group F.
The Journal of Thoracic and CFollow-up was performed during office visits and through telephone
interviews with the patients or their families. Each patient was followed
up for 6 months during the first post-onset year and annually thereafter
at our department or an affiliated hospital. All patients underwent an CT
examination every year.
Statistical Analysis
All the continuous variables are presented as the mean  standard
deviation. Comparisons of the clinical and radiologic characteristics
were performed using chi-square analysis for categorical variables and
Student’s t test for continuous variables. Cox regression analysis was
used to identify the predominant predictors for late aortic events throughout
the follow-up period. The values of actuarial freedom from late aortic
events and survival were computed using the Kaplan-Meier method and
compared using the log-rank test. These data analyses were performed
using StatView, version 5.0, for Windows (SAS Institute, Cary, NC).RESULTS
Group Characteristics
The differences in the basic characteristics among the 4
groups are listed in Table 1. The patients in group F were
younger than those in the other 3 groups (P<.05). Also,
fewer female patients were in group F than in the other 3
groups (P<.05). The number of hypertensive patients did
not significantly differ among the 4 groups. The frequency
of smoking was lower for group T than for the other 3
groups (P<.05). The maximum AD, at onset, was smallest
in group T, with a mean diameter of 34.3  5.6 mm,
compared with 40.5  6.9 mm in group F, 40.7  7.4 mm
in group P, and 53.7  7.3 mm in group U (group T vs
the other 3 groups, P<.05).Number of Crossovers Between Groups
During the follow-up period, some patients experienced
shifts in their lumen status. The number of patients who
crossed into another group is shown in Figure 2. Four
patients (15.4%) shifted from group F to group P. Among
the patients originally classified to group P, 1 (4.3%) moved
to group F, 2 (8.7%) to group U, and 3 (13.0%) to group T.
From the original group U patients, 1 (4.5%) experienced
complete disappearance of the false lumen, but none
moved to any of the other groups. Of the group T patients,p P
19.6%)
Group U
(n ¼ 22; 18.9%)
Group T
(n ¼ 46; 39.3%) P value
12.3 71.5  9.9 71.4  10.6 <.05*
.8 31.8 34.8 <.05*
.3 86.4 80.4 NS
.9 77.3 52.2 <.05y
2.6) 14 (63.6) 32 (69.6) <.05z
7.4 53.7  7.3 34.3  5.6 <.05y
umen; Group P, partially thrombosed false lumen; Group U, ulcer-like projections;
.05, group F versus the other 3 groups. yP<.05, group T versus the other 3 groups.
ardiovascular Surgery c Volume 148, Number 1 99
FIGURE 1. Status of the false lumen at onset, determined using computed tomography images. A, Fully open (group F; fully open false lumen). B, Partially
thrombosed (group P; partially thrombosed false lumen). C, Ulcer-like projections (group U). D, Completely thrombosed (group T; completely thrombosed
false lumen).
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thrombosed false lumen.
Alterations in Maximum AD
The alterations in the maximum AD are listed in Table 2.
The patients who experienced a decrease in their maximum
AD were mostly in group T. Almost all the patients
originally classified to group U developed aortic dilation
during the follow-up period. In group U, only 1 patient
showed a reduction in the maximum AD; the others showed
a rapid increase in the maximum AD.FIGURE 2. Numbers of crossovers among the 4 groups.Group F, Fully open f
projections; Group T, completely thrombosed false lumen.
100 The Journal of Thoracic and Cardiovascular SurgDetails of Late Aortic Events
During the follow-up period, 32 patients (27.4%)
experienced an aortic event, defined as surgery, rupture, or
repeat dissection. Of the 117 patients, 24 (20.5%)
underwent elective surgery, and 1 patient in group
P (0.9%) underwent emergency surgery because of an
increase in the AD. TEVAR was performed in 16 patients
(13.7%): 1 in group F, 6 in group P, and 9 in group U.
Five patients (4.3%) experienced an aortic rupture (3 in
group F and 2 in group U); 2 of the patients survived with
surgery and 3 died suddenly. All the late aortic events thatalse lumen; Group P, partially thrombosed false lumen;Group U, ulcer-like
ery c July 2014
TABLE 2. Alteration in maximum aortic diameter
AD Group F (n ¼ 26) Group P (n ¼ 23) Group U (n ¼ 22) Group T (n ¼ 46) P value
Growth 18 (69.2) 18 (78.3) 19 (86.4) 1 (2.2) <.05*
Shrinkage 1 (3.8) 2 (8.7) 1 (4.5) 17 (37.0) <.05*
Data presented as n (%). Group F, Fully open false lumen; Group P, partially thrombosed false lumen; Group U, ulcer-like projections; Group T, completely thrombosed false
lumen; NS, not significant; AD, aortic diameter. *P<.05, group T versus the other 3 groups.
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followed up during the chronic phase, 95 survived and
22 died, including the 3 with aortic rupture. The other 18
deaths were not caused by aortic events; 6 died of cancer,
7 of heart failure, and 6 of weakness. No hospital deaths
occurred among the patients who underwent surgical aortic
replacement or TEVAR during the chronic phase.
Cumulative Survival and Freedom From Aortic
Events
Figure 3, A, shows the Kaplan-Meier curve indicating the
cumulative survival for all study patients. The mean
follow-up for the 117 patients examined in our analysis
was 5.1  4.1 years (range, 0.1-20.1). The survival rate at
3, 5, and 10 years was 92.8%, 87.1%, and 66.3%, respec-
tively. Figure 3, B, shows the Kaplan-Meier survival curves
stratified by the 4 groups. No significant differences were
found among the 4 groups.
Figure 4, A, shows the Kaplan-Meier curve indicating the
aortic events for the entire study group. The event-free rate
at 3, 5, and 10 years was 78.0%, 72.0%, and 58.4%,
respectively. Figure 4, B, shows the Kaplan-Meier event-
free curves stratified by group. The event-free rate was
greatest in group T, with a 3- and 5-year event-free rate of
100% and 95.7%, respectively. The log-rank test showed
that the event-free rate in group T was significantly higher
than that in the other groups (group T vs group
F, P< .0001; group T vs group P, P ¼ .0009; and group
T vs group U, P<.0001). No significant differences were
found among the other 3 groups. Finally, 8 patients
(50%) experienced an additional aortic event (1 patient in
group F, 6 patients in group P, and 1 patient in group U)
after TEVAR. These additional post-TEVAR aortic events
included a new tear (type I endoleak), migration (type I
endoleak), and new ULP formation.TABLE 3. Details of late aortic events
Late aortic events n (%)
Elective surgery
Descending aortic replacement 4 (12.5)
Thoracoabdominal aortic replacement 1 (3.1)
Total arch replacement 3 (9.4)
Thoracic endovascular aortic repair 16 (50.0)
Emergency surgery
Descending aortic replacement 1 (3.1)
Rupture 3 (9.4)
Repeat dissection 4 (12.5)
The Journal of Thoracic and CaFigure 5, A, shows the Kaplan-Meier survival curves
stratified by the patients who experienced aortic events
(n ¼ 32) and those who did not (n ¼ 85). The 5- and
10-year survival rate was 82.6% and 64.0% in the event
group and 88.4% and 65.8% in the nonevent group,
respectively; these differences were not statistically
significant. Figure 5, B, shows the Kaplan-Meier
event-free curves stratified by the AD at onset in
the patients experiencing aortic events. Of the
117 patients, the AD was 40 mm in 42 and<40 mm
in 75. The 5- and 10-year survival rate was 87.4% and
80.0% in the patients with an initial AD of <40 mm
and 47.5% and 25.9% in the nonevent group for which
the AD was 40 mm. The differences among the groups
were statistically significant (P< .05).Statistical Analysis of Predictors of Late Aortic
Events
The 2 variables correlated with aortic events throughout
the follow-up period. Univariate analysis showed that the
status of the false lumen (group U; P ¼ .018) and the AD
at onset (AD,  40 mm; P<.0001) correlated significantly
with the occurrence of late aortic events. To determine the
statistical significance of the predictor variables, Cox
regression analyses were performed and showed that both
the status of the false lumen (group U; P ¼ .016) and the
AD at onset (AD,  40 mm; P ¼ .0003) were significant
predictors of late aortic events (Table 4).DISCUSSION
The in-hospital outcomes have generally been accept-
able for patients with uncomplicated, acute type B
dissection, with 90% of these patients surviving until
discharge after receiving effective antihypertensive
therapy. Traditionally, stable patients receive conservative
medical treatment (annual survival rate, 80%). However,
the long-term outcomes have remained sobering because
of aneurysmal expansion of the false lumens and late
complications.7-9 Persistent false lumen perfusion has
consistently been identified as a risk factor for adverse
outcomes, and complete thrombosis has been associated
with improved outcomes.10-13 Some investigators have
reported that if the maximum AD is <45 mm at the
onset of dissection, the risk of a later increase is
small; however, other researchers have argued that a
small AD (<40 mm) does not lessen the risk of futurerdiovascular Surgery c Volume 148, Number 1 101
FIGURE 3. A, Cumulative survival of the entire study group. B, Cumulative survival of each group. P values were calculated using the log-rank test.Group
F, Fully open false lumen; Group P, partially thrombosed false lumen; Group U, ulcer-like projections; Group T, completely thrombosed false lumen.
Acquired Cardiovascular Disease Kudo et al
A
C
Denlargement.14-16 Many studies have identified predictors
of late aortic events.12,17,18
In the present series, patients with patent false lumens
(groups F and P) and ULPs (group U) had a greater tendency
to have an enlarged AD than those with completely
thrombosed false lumens (group T; Table 2). In addition,
completely thrombosed false lumens (group T) had
a greater tendency to disappear but did not shift to
patent false lumens or ULPs. Completely thrombosed false
lumens were, therefore, more likely to undergo aortic
remodeling.
Expansion of the AD during the chronic phase of type B
AAD is primarily caused by enlargement of the patent false
lumen (groups F and P) and ULPs (group U), and
patients with these signs have a significant tendency to
require surgical intervention or experience aortic rupture
(Figure 4, B).
The present study has shown that a late aortic event in
patients with type B AAD correlated with 2 independent
predictors: the false lumen status (ULPs; group U) and a
maximum AD  40 mm at onset. Previous studies have
suggested that the risks of late aortic events are greater
for patients with patent false lumens than for those with
thrombosed false lumens.15,19-22 The present study, which
included a relatively large cohort and had a long follow-FIGURE 4. A, Freedom from aortic events in the entire study group. B, Free
log-rank test.Group F, Fully open false lumen;Group P, partially thrombosed fal
false lumen.
102 The Journal of Thoracic and Cardiovascular Surgup period, has demonstrated that the prognosis of patients
with completely thrombosed false lumens (group T)
was as good as that of patients with patent false lumens
(groups F and P) and ULPs (group U; Table 4). This finding
indicates that the surgical results were acceptable and that
successful outcomes were obtained for the surgical
interventions during a long follow-up period. Patients
with patent false lumens (groups F and P) and ULPs (group
U) had no significant cumulative survival advantage
compared with patients with a completely thrombosed false
lumen (group T; Figure 3, B).
In the present study, 16 patients underwent TEVAR
during the late chronic phase. Although TEVAR provided
a survival benefit with respect to the survival rate, 50%
of the patients who underwent TEVAR had a complica-
tion, such as an endoleak or the formation of a new
tear. One ULP patient experienced a complication after
TEVAR. Our report has indicated that groups F and P
had high rates of complications after TEVAR. Because
ULPs might be treated as aneurysms, our results have
shown that TEVAR has greater merit for patients with
ULPs (group U) than for those with false lumens
(groups F and P).
In summary, late survival did not differ among patients
classified according to the type of false lumen present.dom from aortic events in each group. P values were calculated using the
se lumen;GroupU, ulcer-like projections;Group T, completely thrombosed
ery c July 2014
FIGURE 5. A, Cumulative survival for the event group (n¼ 32) and nonevent group (n¼ 85). P values were calculated using the log-rank test. B, Freedom
from aortic events in patients with an aortic diameter 40 mm (n¼ 42) at onset and aortic diameter<40 mm (n¼ 75). P values were calculated using the
log-rank test.
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DThe incidence of late aortic events was lower among
patients with thrombosed false lumens, but no significant
difference was found among the other 3 groups. Patients
who experienced aortic events but underwent intervention
at the appropriate time did not exhibit significant changes
in their survival rate among the groups.A
CStudy Limitations
Only 70.9% patients were available for follow-up, and
some of those patients had a relatively short follow-up
period. Additionally, we used handmade stent grafts for
TEVAR for the patients described in the present study.
Currently, stent grafts are commercially available. How-
ever, if commercially available stent grafts had been
available for use in the patients in the present study, we
believe that the occurrence of additional aortic events might
have been reduced after TEVAR.CONCLUSIONS
We evaluated the prognosis of patients with type B AAD
who had received medical treatment during their initial
hospitalization. The incidence of late aortic events was
greater among the patients with patent false lumens and
ULPs. When patients had a maximum AD of 40 mm,
or ULPs, at onset, careful and regular follow-up CT
examinations are required, and early surgical intervention
should also be considered.TABLE 4. Statistical analysis of predictors of late aortic events
Variable
Univariate
P value
Cox proportional hazard analysis
P value HR 95% CI
Age .6035 — — —
Female gender .2017 — — —
Hypertension .9788 — — —
Smoking .1441 — — —
DeBakey type IIIb .9296 — — —
Group U .018 .016 2.499 1.186-5.266
AD>40 mm at onset <.0001 .0003 4.072 1.914-8.665
HR, Hazard ratio; CI, confidence interval; Group U, ulcer-like projections;
AD, aortic diameter.
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